The Endogenous Metabolite TDCA Ameliorates LPS-Driven Liver Injury via Modulation of Caspase-11/GSDMD-Mediated Pyroptosis
International Journal of Molecular Sciences · 28.02.2026 · 27 (5) · 2273
DOI: 10.3390/ijms27052273 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 28.02.2026. Verfasst von Deqing Ruan und 7 weiteren Autor:innen. Beteiligte Einrichtung: Yunnan Key Laboratory of Southern Medicine Utilization, Yunnan University of Chinese Medicine, 1076 Yuhua Road, Kunming 650500, China. Hauptthemen laut MEDLINE: Lipopolysaccharides, Pyroptosis, Caspases, Initiator, Liver. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Yunnan Xingdian Talent Plan Innovation Team Project.
Abstract (Originalsprache)
The liver is a central immunometabolic organ during endotoxemia and a major target of sepsis-related injury. Intriguingly, the liver exhibits a notable resilience to endotoxemia or septic insults, suggesting the activation of endogenous protective mechanisms. The bile acid taurodeoxycholic acid (TDCA) demonstrates hepatoprotective properties; nonetheless, its role and mechanism in lipopolysaccharide (LPS)-driven inflammatory liver injury remain elusive. This study reveals that LPS challenge induces significant reprogramming of hepatic bile acid metabolism, with TDCA being markedly elevated in LPS-challenged mice. In vitro, TDCA dose-dependently attenuated pyroptosis in bone marrow-derived macrophages, as evidenced by reduced lactate dehydrogenase (LDH) release, decreased interleukin-1 beta (IL-1β) and interleukin-18 (IL-18) secretion, and suppressed dye Oxazole yellow uptake. Consistent with reduced non-canonical inflammasome signaling, TDCA treatment was associated with decreased activation of caspase-11 and its downstream targets Gasdermin D (GSDMD) and IL-1β. In a lethal D-Galactosamine (D-GalN)/LPS-induced toxin-sensitized inflammatory liver injury model, therapeutic administration of TDCA (3, 6 mg/kg) profoundly improved survival rates (40% and 80%, respectively), attenuated liver injury, reduced alanine aminotransferase (ALT) and aspartate aminotransferase (AST), suppressed systemic inflammation (IL-1β and IL-18), and ameliorated histopathological damage. Crucially, TDCA treatment reduced the activation of the caspase-11/GSDMD pathway in the septic liver. Our findings demonstrate that TDCA is an endogenously mobilized bile acid that confers protection against LPS-driven inflammatory liver injury, with effects supporting a role for modulation of the Caspase-11/GSDMD pyroptotic pathway. These observations provide hypothesis-generating implications for sepsis-associated liver injury that warrant further validation in clinically relevant sepsis models and pathway-necessity studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Yunnan Key Laboratory of Southern Medicine Utilization, Yunnan University of Chinese Medicine, 1076 Yuhua Road, Kunming 650500, China.
- School of Chinese Materia Medica, Yunnan University of Chinese Medicine, 1076 Yuhua Road, Kunming 650500, China.
- Jiangxi Province Key Laboratory of Sustainable Utilization of Traditional Chinese Medicine Resources, Institute of Traditional Chinese Medicine Health Industry, China Academy of Chinese Medical Sciences, Nanchang 330115…
Förderung
- National Natural Science Foundation of China
- Yunnan Xingdian Talent Plan Innovation Team Project
Zitieren
APA
Ruan, D., Yan, X., Tang, Y., Yang, S., Yang, X., Zhang, M., Yu, S., & Yu, J. (2026). The Endogenous Metabolite TDCA Ameliorates LPS-Driven Liver Injury via Modulation of Caspase-11/GSDMD-Mediated Pyroptosis. International Journal of Molecular Sciences, 27(5), 2273. https://doi.org/10.3390/ijms27052273
Vancouver
Ruan D, Yan X, Tang Y, Yang S, Yang X, Zhang M, et al. The Endogenous Metabolite TDCA Ameliorates LPS-Driven Liver Injury via Modulation of Caspase-11/GSDMD-Mediated Pyroptosis. International Journal of Molecular Sciences. 2026;27(5):2273. doi:10.3390/ijms27052273
BibTeX
@article{Ruan2026,
author = {Ruan, Deqing and Yan, Xing and Tang, Yanmei and Yang, Shunhua and Yang, Xinxin and Zhang, Mei and Yu, Shibo and Yu, Jie},
title = {The Endogenous Metabolite TDCA Ameliorates LPS-Driven Liver Injury via Modulation of Caspase-11/GSDMD-Mediated Pyroptosis},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {5},
pages = {2273},
doi = {10.3390/ijms27052273}
}
EUVIMED